United States · FDA National Drug Code directory

OCTREOTIDE ACETATE

Source ingredient · 33 source records

Names are grouped within this source and country. A shared ingredient does not establish interchangeable medicines.

United States · Source reference 62756-452_ee3c8bae-88f0-4b76-80af-98a3e3312585

BYNFEZIA Pen

INJECTION / Sun Pharmaceutical Industries, Inc.

United States · Source reference 23155-685_b90ce9b0-5886-4b4f-a721-9698fa28a7ec

OCTREOTIDE ACETATE

INJECTION, SOLUTION / Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

United States · Source reference 23155-686_b90ce9b0-5886-4b4f-a721-9698fa28a7ec

OCTREOTIDE ACETATE

INJECTION, SOLUTION / Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

United States · Source reference 23155-687_b90ce9b0-5886-4b4f-a721-9698fa28a7ec

OCTREOTIDE ACETATE

INJECTION, SOLUTION / Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

United States · Source reference 23155-688_b90ce9b0-5886-4b4f-a721-9698fa28a7ec

OCTREOTIDE ACETATE

INJECTION, SOLUTION / Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

United States · Source reference 23155-689_b90ce9b0-5886-4b4f-a721-9698fa28a7ec

OCTREOTIDE ACETATE

INJECTION, SOLUTION / Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

United States · Source reference 52958-046_dc2c72fd-ddb4-4933-8ef2-1edfbe7740f2

OCTREOTIDE ACETATE

INJECTION, SOLUTION / Hainan Shuangcheng Pharmaceuticals Co., Ltd.

United States · Source reference 63323-376_02ac0091-573d-41ba-8b4d-5a1d42b89b2e

Octreotide

INJECTION, SOLUTION / Fresenius Kabi USA, LLC

United States · Source reference 63323-376_d8819119-418c-494a-8ab5-d9502c7aed93

Octreotide

INJECTION, SOLUTION / Fresenius Kabi USA, LLC

United States · Source reference 63323-377_02ac0091-573d-41ba-8b4d-5a1d42b89b2e

Octreotide

INJECTION, SOLUTION / Fresenius Kabi USA, LLC

United States · Source reference 63323-377_d8819119-418c-494a-8ab5-d9502c7aed93

Octreotide

INJECTION, SOLUTION / Fresenius Kabi USA, LLC

United States · Source reference 63323-378_02ac0091-573d-41ba-8b4d-5a1d42b89b2e

Octreotide

INJECTION, SOLUTION / Fresenius Kabi USA, LLC

United States · Source reference 63323-379_02ac0091-573d-41ba-8b4d-5a1d42b89b2e

Octreotide

INJECTION, SOLUTION / Fresenius Kabi USA, LLC

United States · Source reference 0641-6174_efa5d8e8-57ab-4b56-b8d7-f856ea97404c

Octreotide Acetate

INJECTION, SOLUTION / Hikma Pharmaceuticals USA Inc.

United States · Source reference 0641-6175_efa5d8e8-57ab-4b56-b8d7-f856ea97404c

Octreotide Acetate

INJECTION, SOLUTION / Hikma Pharmaceuticals USA Inc.

United States · Source reference 0641-6176_efa5d8e8-57ab-4b56-b8d7-f856ea97404c

Octreotide Acetate

INJECTION, SOLUTION / Hikma Pharmaceuticals USA Inc.

United States · Source reference 0641-6177_efa5d8e8-57ab-4b56-b8d7-f856ea97404c

Octreotide Acetate

INJECTION, SOLUTION / Hikma Pharmaceuticals USA Inc.

United States · Source reference 0641-6178_efa5d8e8-57ab-4b56-b8d7-f856ea97404c

Octreotide Acetate

INJECTION, SOLUTION / Hikma Pharmaceuticals USA Inc.

United States · Source reference 67457-239_1bb19829-029a-4baf-a12c-ec04102dd79e

Octreotide Acetate

INJECTION, SOLUTION / Mylan Institutional LLC

United States · Source reference 67457-245_1bb19829-029a-4baf-a12c-ec04102dd79e

Octreotide Acetate

INJECTION, SOLUTION / Mylan Institutional LLC

United States · Source reference 67457-246_1bb19829-029a-4baf-a12c-ec04102dd79e

Octreotide Acetate

INJECTION, SOLUTION / Mylan Institutional LLC

United States · Source reference 68083-515_5869eaa3-e390-4dff-97df-1adf431ef64f

Octreotide Acetate

INJECTION, SOLUTION / Gland Pharma Limited

United States · Source reference 68083-516_5869eaa3-e390-4dff-97df-1adf431ef64f

Octreotide Acetate

INJECTION, SOLUTION / Gland Pharma Limited

United States · Source reference 68083-517_723308d0-ea28-4f3f-b993-0bc5cfe33cfe

Octreotide Acetate

INJECTION, SOLUTION / Gland Pharma Limited

United States · Source reference 68083-560_723308d0-ea28-4f3f-b993-0bc5cfe33cfe

Octreotide Acetate

INJECTION, SOLUTION / Gland Pharma Limited

United States · Source reference 68462-896_1a5d8576-7695-42f0-871a-d8de8c7b0220

Octreotide Acetate

INJECTION, SOLUTION / GLENMARK PHARMACEUTICALS INC., USA

United States · Source reference 68462-897_1a5d8576-7695-42f0-871a-d8de8c7b0220

Octreotide Acetate

INJECTION, SOLUTION / GLENMARK PHARMACEUTICALS INC., USA

United States · Source reference 71288-566_a12a7206-6077-4b61-a038-4aae1170b387

Octreotide Acetate

INJECTION, SOLUTION / Meitheal Pharmaceuticals, Inc.

United States · Source reference 71288-567_a12a7206-6077-4b61-a038-4aae1170b387

Octreotide Acetate

INJECTION, SOLUTION / Meitheal Pharmaceuticals, Inc.

United States · Source reference 71288-568_a12a7206-6077-4b61-a038-4aae1170b387

Octreotide Acetate

INJECTION, SOLUTION / Meitheal Pharmaceuticals, Inc.

Browse ingredients in United States →